Economic impacts of ending performance uses of antibiotics

Economic impacts of ending performance uses of antibiotics

John Maday

Bovine Veterinarian

The livestock industry faces growing pressures to reduce antibiotic use, particularly the use of medically important drugs for production or performance purposes. In response, the FDA issued its Guidance for Industry 213, which directs companies to remove performance claims from antibiotic labels by December 2016.

Full Story

Comments are closed.